Yuan Yun-Fei, Li Bin-Kui, Li Jin-Qing, Zhang Ya-Qi, Guo Rong-Ping, Lin Xiao-Jun, Li Guo-Hui
Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P.R.China.
Ai Zheng. 2004 Jul;23(7):821-4.
BACKGROUND & OBJECTIVE: Primary liver cancer (PLC) larger than 10 cm in diameter is called huge PLC. Huge PLC accounts for a number of patients at the time of diagnosis in clinical practice. The outcome of resection in these patients has not been clearly demonstrated. This study was to evaluate the outcome and determined the prognostic factors affecting long-term survival following hepatectomy for huge PLC.
One hundred and seventy-three patients with huge PLC who underwent hepatectomy from 1964 to 1993 were followed up to January 2003 and reviewed retrospectively. The factors affecting long-term survival were studied by univariate and multivariate analysis.
The overall 3-, 5-, and 10-year survival rates were 31.9%, 21.8%, and 8.3%, respectively. Thirty-seven patients survived more than 5 years and 8 patients survived more than 10 years. Univariate analysis showed that sex, Child-Pugh classification, degree of coexisting cirrhosis and radical resection were significant prognostic factors. The Cox multivariate proportional hazard model indicated that independent prognostic factors for long-term survival were degree of coexisting cirrhosis and radical resection.
Hepatic resection for huge PLC offers the chance of long-term survival. It should be used to treat patients with huge PLC at first choice. Degree of coexisting cirrhosis and radical resection were the only two prognostic factors for long-term survival following hepatectomy for huge PLC.
直径大于10cm的原发性肝癌(PLC)被称为巨大PLC。在临床实践中,巨大PLC在确诊时占一定比例的患者。这些患者肝切除术后的结果尚未得到明确证实。本研究旨在评估巨大PLC肝切除术后的结果,并确定影响长期生存的预后因素。
对1964年至1993年间接受肝切除术的173例巨大PLC患者进行随访至2003年1月,并进行回顾性分析。通过单因素和多因素分析研究影响长期生存的因素。
总体3年、5年和10年生存率分别为31.9%、21.8%和8.3%。37例患者存活超过5年,8例患者存活超过10年。单因素分析显示,性别、Child-Pugh分级、并存肝硬化程度和根治性切除是显著的预后因素。Cox多因素比例风险模型表明,长期生存的独立预后因素是并存肝硬化程度和根治性切除。
巨大PLC肝切除术提供了长期生存的机会。应将其作为巨大PLC患者的首选治疗方法。并存肝硬化程度和根治性切除是巨大PLC肝切除术后长期生存的仅有的两个预后因素。